Revive Therapeutics (RVV) Price & Analysis

Q: What was Revive Therapeutics Ltd’s price range in the past 12 months?

Revive Therapeutics Ltd lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.

Q: What is Revive Therapeutics Ltd’s market cap?

Revive Therapeutics Ltd’s market cap is C$6.28M.

Q: When is Revive Therapeutics Ltd’s upcoming earnings report date?

Revive Therapeutics Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 76 days.

Q: Is Revive Therapeutics Ltd overvalued?

According to Wall Street analysts Revive Therapeutics Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Revive Therapeutics Ltd pay dividends?

Revive Therapeutics Ltd does not currently pay dividends.

Q: What is Revive Therapeutics Ltd’s EPS estimate?

Revive Therapeutics Ltd’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Revive Therapeutics Ltd have?

Revive Therapeutics Ltd has 418,564,270 shares outstanding.

Q: Which hedge fund is a major shareholder of Revive Therapeutics Ltd?

Currently, no hedge funds are holding shares in TSE:RVV

Q: What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Compare

133 Followers

RVV Stock Chart & Stats

C$0.02

C$0.00(0.00%)

At close: Jan 08 4:00 PM EST

C$0.02

C$0.00(0.00%)

Day’s Range― - ―

52-Week Range<C$0.01 - C$0.04

Previous CloseN/A

Volume2.50K

Average Volume (3M)285.50K

Market Cap

C$6.28M

Enterprise ValueC$6.29M

Total Cash (Recent Filing)C$46.42K

Total Debt (Recent Filing)C$65.57K

Price to Earnings (P/E)―

Beta3.21

Next Earnings

Mar 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding418,564,270

10 Day Avg. Volume295,136

30 Day Avg. Volume285,498

Financial Highlights & Ratios

PEG Ratio0.03

Price to Book (P/B)0.53

Price to Sales (P/S)0.00

P/FCF Ratio-1.16

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Revive Therapeutics News

Revive Therapeutics provides update on nerve agent countmeasure study

Revive Therapeutics (RVVTF) announced an update on its ongoing research study evaluating Bucillamine as a potential treatment for...

3d ago

Revive Therapeutics says nerve agent countmeasure study ‘remains in progress’

Revive Therapeutics (RVVTF) announced an update on its ongoing research study evaluating Bucillamine as a potential treatment for...

26d ago

Revive Therapeutics Updates on Nerve Agent Countermeasure Study

An announcement from Revive Therapeutics ( ($TSE:RVV) ) is now available. Revive Therapeutics has announced an update on...

3d ago

Revive Therapeutics Updates on Nerve Agent Countermeasure Study

The latest announcement is out from Revive Therapeutics ( ($TSE:RVV) ). Revive Therapeutics announced an update on its...

26d ago

Revive Therapeutics Closes Second Tranche of Private Placement

Revive Therapeutics ( ($TSE:RVV) ) has provided an announcement. Revive Therapeutics announced the closing of the second tranche...

3M ago

Revive Therapeutics Extends Private Placement to Support Therapeutic Programs

The latest announcement is out from Revive Therapeutics ( ($TSE:RVV) ). Revive Therapeutics Ltd. announced an extension of...

3M ago

Revive Therapeutics Completes First Tranche of Private Placement and Debt Settlement

Revive Therapeutics ( ($TSE:RVV) ) has issued an update. Revive Therapeutics has completed the first tranche of its...

4M ago

Revive Therapeutics Announces Private Placement and Debt Settlement Plan

Revive Therapeutics ( ($TSE:RVV) ) has issued an announcement. Revive Therapeutics Ltd. announced a proposed private placement offering...

5M ago

Revive Therapeutics Updates on Nerve Agent Countermeasure Study

An update from Revive Therapeutics ( ($TSE:RVV) ) is now available. Revive Therapeutics has clarified the status of...

5M ago

Revive Therapeutics Advances Nerve Agent Countermeasure Study with Canadian Defence

Revive Therapeutics ( ($TSE:RVV) ) just unveiled an announcement. Revive Therapeutics is nearing the completion of a key...

6M ago

Revive Therapeutics nears completion of nerve agent countermeasure study

Revive Therapeutics (RVVTF) announced an update on the research study evaluating Bucillamine as a potential treatment for nerve...

6M ago

Revive Therapeutics Advances Next-Gen Bucillamine for Critical Medical Needs

Revive Therapeutics ( ($TSE:RVV) ) has issued an update. Revive Therapeutics Ltd. has announced the advancement of its...

7M ago

Revive Therapeutics Advances Bucillamine Research for Nerve Agent Exposure

An update from Revive Therapeutics ( ($TSE:RVV) ) is now available. Revive Therapeutics has announced an update on...

7M ago

Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

8M ago

ATAI

CMND

RVV FAQ

What was Revive Therapeutics Ltd’s price range in the past 12 months?

Revive Therapeutics Ltd lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.

What is Revive Therapeutics Ltd’s market cap?

Revive Therapeutics Ltd’s market cap is C$6.28M.

When is Revive Therapeutics Ltd’s upcoming earnings report date?

Revive Therapeutics Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 76 days.

How were Revive Therapeutics Ltd’s earnings last quarter?

Currently, no data Available

Is Revive Therapeutics Ltd overvalued?

According to Wall Street analysts Revive Therapeutics Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Revive Therapeutics Ltd pay dividends?

Revive Therapeutics Ltd does not currently pay dividends.

What is Revive Therapeutics Ltd’s EPS estimate?

Revive Therapeutics Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Revive Therapeutics Ltd have?

Revive Therapeutics Ltd has 418,564,270 shares outstanding.

What happened to Revive Therapeutics Ltd’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Revive Therapeutics Ltd?

Currently, no hedge funds are holding shares in TSE:RVV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Revive Therapeutics Ltd

Revive Therapeutics Ltd. is a life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. Operating primarily in the biopharmaceutical sector, the company is committed to the advancement of innovative treatments leveraging its unique platform to address unmet medical needs in areas such as infectious diseases, rare disorders, and chronic pain management.